{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:24:55Z","timestamp":1761848695100,"version":"build-2065373602"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Xinjiang","award":["2022D01A131"],"award-info":[{"award-number":["2022D01A131"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160784","82160784","82160784"],"award-info":[{"award-number":["82160784","82160784","82160784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Initiative for Innovative Medicine","doi-asserted-by":"crossref","award":["2021-I2M-1-030","2021-I2M-1-030","2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030","2021-I2M-1-030","2021-I2M-1-030"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02970-w","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:22:24Z","timestamp":1761564144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sophora alopecuroides biflavones glycoside, isolated from Sophora alopecuroides, inhibits the secretion of hepatitis B virus surface antigen through direct interaction with its antigenic loop domain"],"prefix":"10.1186","volume":"22","author":[{"given":"Ya","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"2970_CR1","first-page":"65","volume":"124","author":"Z Marjenberg","year":"2022","unstructured":"Marjenberg Z, Wright C, Pooley N, Cheung K, Shimakawa Y, Vargas-Zambrano J et al. HBsAg prevalence and the rates of mother-to-child transmission of hepatitis B virus following the introduction of infant vaccination programmes in South East Asia and Western Pacific regions: a systematic review. Int J Infect Dis: IJID : Official Publ Int Soc Infect Dis. 2022;124:65\u201375.","journal-title":"Int J Infect Dis: IJID : Official Publ Int Soc Infect Dis"},{"issue":"6","key":"2970_CR2","doi-asserted-by":"publisher","first-page":"e0156667","DOI":"10.1371\/journal.pone.0156667","volume":"11","author":"M Al-Mahtab","year":"2016","unstructured":"Al-Mahtab M, Bazinet M, Vaillant A. Safety and efficacy of nucleic acid polymers in monotherapy and combined with immunotherapy in treatment-naive Bangladeshi patients with HBeAg\u2009+\u2009chronic hepatitis B infection. PLoS ONE. 2016;11(6):e0156667.","journal-title":"PLoS ONE"},{"issue":"6","key":"2970_CR3","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/hep.28025","volume":"62","author":"TJ Liang","year":"2015","unstructured":"Liang TJ, Block TM, Mcmahon BJ, Ghany MG, Lok AS. Present and future therapies of hepatitis B: from discovery to cure. Hepatology. 2015;62(6):1893\u2013908. https:\/\/doi.org\/10.1002\/hep.28025.","journal-title":"Hepatology"},{"issue":"6","key":"2970_CR4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","volume":"76","author":"GLH Wong","year":"2022","unstructured":"Wong GLH, Gane E, Lok ASF. How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development? J Hepatology: J Eur Assoc Stud Liver. 2022;76(6):1249\u201362.","journal-title":"J Hepatology: J Eur Assoc Stud Liver"},{"key":"2970_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11121862","author":"F Mahmood","year":"2023","unstructured":"Mahmood F, Xu R, Awan MUN, Song Y, Han Q, Xia X, et al. HBV vaccines: advances and development. Vaccines. 2023. https:\/\/doi.org\/10.3390\/vaccines11121862.","journal-title":"Vaccines"},{"issue":"6","key":"2970_CR6","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1021\/acsinfecdis.0c00638","volume":"7","author":"A Vaillant","year":"2021","unstructured":"Vaillant A, HBsAg. Subviral Particles, and their clearance in Establishing a functional cure of chronic hepatitis B virus infection. ACS Infect Dis. 2021;7(6):1351\u201368.","journal-title":"ACS Infect Dis"},{"issue":"3","key":"2970_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/v9030056","volume":"9","author":"J Hu","year":"2017","unstructured":"Hu J, Liu K. Complete and incomplete hepatitis B virus particles: formation, function, and application. Viruses. 2017;9(3):56. https:\/\/doi.org\/10.3390\/v9030056.","journal-title":"Viruses"},{"issue":"8","key":"2970_CR8","doi-asserted-by":"publisher","first-page":"e02399","DOI":"10.1128\/JVI.02399-20","volume":"95","author":"S Yang","year":"2021","unstructured":"Yang S, Shen Z, Kang Y, Sun L, Viswanathan U, Guo H, et al. A putative amphipathic alpha helix in hepatitis B virus small envelope protein plays a critical role in the morphogenesis of subviral particles. J Virol. 2021;95(8):e02399\u201320. https:\/\/doi.org\/10.1128\/JVI.02399-20.","journal-title":"J Virol"},{"key":"2970_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105955","volume":"228","author":"B Shrestha","year":"2024","unstructured":"Shrestha B, Yang S, Griffith L, Ma J, Wang F, Liu H, et al. Discovery of hepatitis B virus subviral particle biogenesis inhibitors from a bioactive compound library. Antiviral Res. 2024;228:105955.","journal-title":"Antiviral Res"},{"issue":"1","key":"2970_CR10","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/s41598-020-58870-2","volume":"10","author":"JH Kim","year":"2020","unstructured":"Kim JH, Ghosh A, Ayithan N, Romani S, Khanam A, Park JJ, et al. Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients. Sci Rep. 2020;10(1):1835.","journal-title":"Sci Rep"},{"issue":"2","key":"2970_CR11","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/j.gastro.2020.04.019","volume":"159","author":"N Le Bert","year":"2020","unstructured":"Le Bert N, Gill US, Hong M, Kunasegaran K, Tan DZM, Ahmad R, et al. Effects of hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection. Gastroenterology. 2020;159(2):652\u201364.","journal-title":"Gastroenterology"},{"key":"2970_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1257113","volume":"14","author":"S Takahama","year":"2023","unstructured":"Takahama S, Yoshio S, Masuta Y, Murakami H, Sakamori R, Kaneko S, et al. Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8(+) T cell quality. Front Immunol. 2023;14:1257113.","journal-title":"Front Immunol"},{"issue":"10","key":"2970_CR13","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1172\/JCI121960","volume":"128","author":"AR Burton","year":"2018","unstructured":"Burton AR, Pallett LJ, McCoy LE, Suveizdyte K, Amin OE, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128(10):4588\u2013603.","journal-title":"J Clin Invest"},{"issue":"10","key":"2970_CR14","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1172\/JCI121957","volume":"128","author":"L Salimzadeh","year":"2018","unstructured":"Salimzadeh L, Le Bert N, Dutertre CA, Gill US, Newell EW, Frey C, et al. PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection. J Clin Invest. 2018;128(10):4573\u201387.","journal-title":"J Clin Invest"},{"key":"2970_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105782","volume":"221","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Liu H, Tang L, Wang F, Tolufashe G, Chang J, et al. Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy. Antivir Res. 2024;221:105782.","journal-title":"Antivir Res"},{"issue":"1","key":"2970_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.antiviral.2006.12.005","volume":"74","author":"Z Zhou","year":"2007","unstructured":"Zhou Z, Zhang Y, Ding XR, Chen SH, Yang J, Wang XJ, et al. Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo. Antiviral Res. 2007;74(1):59\u201364.","journal-title":"Antiviral Res"},{"key":"2970_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jep.2015.10.032","volume":"176","author":"CA Geng","year":"2015","unstructured":"Geng CA, Huang XY, Chen XL, Ma YB, Rong GQ, Zhao Y, et al. Three new anti-HBV active constituents from the traditional Chinese herb of Yin-Chen (Artemisia scoparia). J Ethnopharmacol. 2015;176:109\u201317.","journal-title":"J Ethnopharmacol"},{"key":"2970_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jep.2018.06.005","volume":"224","author":"CA Geng","year":"2018","unstructured":"Geng CA, Yang TH, Huang XY, Yang J, Ma YB, Li TZ, et al. Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes. J Ethnopharmacol. 2018;224:283\u20139.","journal-title":"J Ethnopharmacol"},{"key":"2970_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111972","volume":"188","author":"Y Li","year":"2020","unstructured":"Li Y, Wang G, Liu J, Ouyang L. Quinolizidine alkaloids derivatives from sophora alopecuroides linn: Bioactivities, structure-activity relationships and preliminary molecular mechanisms. Eur J Med Chem. 2020;188:111972.","journal-title":"Eur J Med Chem"},{"key":"2970_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112172","volume":"248","author":"R Wang","year":"2020","unstructured":"Wang R, Deng X, Gao Q, Wu X, Han L, Gao X, et al. Sophora alopecuroides L.: an ethnopharmacological, phytochemical, and pharmacological review. J Ethnopharmacol. 2020;248:112172.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"2970_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1142\/S0192415X23500167","volume":"51","author":"T Sun","year":"2023","unstructured":"Sun T, Chen L, Liu R, Liu QS, Cheng Y. Sophora alopecuroides alleviates neuroinflammation and oxidative damage of parkinson\u2019s disease in vitro and in vivo. Am J Chin Med. 2023;51(2):309\u201328.","journal-title":"Am J Chin Med"},{"key":"2970_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104781","volume":"110","author":"JC Li","year":"2021","unstructured":"Li JC, Dai WF, Liu D, Zhang ZJ, Jiang MY, Rao KR, et al. Quinolizidine alkaloids from sophora alopecuroides with anti-inflammatory and anti-tumor properties. Bioorg Chem. 2021;110:104781.","journal-title":"Bioorg Chem"},{"issue":"1","key":"2970_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/cam4.1269","volume":"7","author":"W Li","year":"2018","unstructured":"Li W, Yu X, Tan S, Liu W, Zhou L, Liu H. Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway. Cancer Med. 2018;7(1):208\u201318.","journal-title":"Cancer Med"},{"issue":"3","key":"2970_CR24","first-page":"154","volume":"71","author":"B Lin","year":"2016","unstructured":"Lin B, Li D, Zhang L. Oxymatrine mediates Bax and Bcl-2 expression in human breast cancer MCF-7 cells. Pharmazie. 2016;71(3):154\u20137.","journal-title":"Pharmazie"},{"key":"2970_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.phytochem.2015.02.022","volume":"116","author":"CX Wan","year":"2015","unstructured":"Wan CX, Luo JG, Ren XP, Kong LY. Interconverting flavonostilbenes with antibacterial activity from sophora alopecuroides. Phytochemistry. 2015;116:290\u20137.","journal-title":"Phytochemistry"},{"key":"2970_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.intimp.2017.12.006","volume":"55","author":"J Liang","year":"2018","unstructured":"Liang J, Chang B, Huang M, Huang W, Ma W, Liu Y, et al. Oxymatrine prevents synovial inflammation and migration via blocking NF-\u03baB activation in rheumatoid fibroblast-like synoviocytes. Int Immunopharmacol. 2018;55:105\u201311.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"2970_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1055\/s-0035-1546153","volume":"81","author":"Y Yang","year":"2015","unstructured":"Yang Y, Li YX, Wang HL, Jin SJ, Zhou R, Qiao HQ, et al. Oxysophocarpine ameliorates carrageenan-induced inflammatory pain via inhibiting expressions of prostaglandin E2 and cytokines in mice. Planta Med. 2015;81(10):791\u20137.","journal-title":"Planta Med"},{"key":"2970_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116723","volume":"316","author":"J Li","year":"2023","unstructured":"Li J, Zhang M, Pei Y, Yang Q, Zheng L, Wang G, et al. The total alkaloids of sophora alopecuroides L. improve depression-like behavior in mice via BDNF-mediated AKT\/mTOR signaling pathway. J Ethnopharmacol. 2023;316:116723.","journal-title":"J Ethnopharmacol"},{"key":"2970_CR29","doi-asserted-by":"publisher","first-page":"926123","DOI":"10.3389\/fphar.2022.926123","volume":"13","author":"XW Li","year":"2022","unstructured":"Li XW, Lu YY, Zhang SY, Sai NN, Fan YY, Cheng Y, et al. Mechanism of neural regeneration induced by natural product LY01 in the 5\u00d7FAD mouse model of alzheimer\u2019s disease. Front Pharmacol. 2022;13:926123.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2970_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1208\/s12249-014-0086-y","volume":"15","author":"S Zhang","year":"2014","unstructured":"Zhang S, Wu J, Wang H, Wang T, Jin L, Shu D, et al. Liposomal oxymatrine in hepatic fibrosis treatment: formulation, in vitro and in vivo assessment. AAPS PharmSciTech. 2014;15(3):620\u20139.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2970_CR31","first-page":"69","volume":"3","author":"Y Long","year":"2004","unstructured":"Long Y, Lin XT, Zeng KL, Zhang L. Efficacy of intramuscular matrine in the treatment of chronic hepatitis B. Hepatobiliary Pancreat Dis Int. 2004;3(1):69\u201372.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"7","key":"2970_CR32","first-page":"505","volume":"17","author":"CX Chen","year":"2009","unstructured":"Chen CX, Liu B, Ma Y, Zhou YJ, Pan XN, Zhen RD, et al. [Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B]. Zhonghua Gan Zang Bing Za Zhi. 2009;17(7):505\u20138.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"3","key":"2970_CR33","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3748\/wjg.v11.i3.426","volume":"11","author":"CQ Li","year":"2005","unstructured":"Li CQ, Zhu YT, Zhang FX, Fu LC, Li XH, Cheng Y, et al. Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo. World J Gastroenterol. 2005;11(3):426\u20138.","journal-title":"World J Gastroenterol"},{"issue":"17","key":"2970_CR34","first-page":"21","volume":"26","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Yang Q, Li Z, Liu Y, Huang H. The inhibitory effect of the total flavonoids Ertracts from sophora alopecuroides L. on replicaion of hepatitis B virus. Chin J Ethnomed Ethnopharmacy. 2017;26(17):21\u20134.","journal-title":"Chin J Ethnomed Ethnopharmacy"},{"issue":"1","key":"2970_CR35","first-page":"72","volume":"37","author":"HT Bian","year":"2014","unstructured":"Bian HT, Zhao J, Huang H, Yang Ql, Liu Y. Chemical constl Tuents from seeds of sophora alopecuroide. J Chin Med Mater. 2014;37(1):72\u20133.","journal-title":"J Chin Med Mater"},{"issue":"10","key":"2970_CR36","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.3390\/molecules27103223","volume":"27","author":"L Yang","year":"2022","unstructured":"Yang L, Wang H, Yan H, Wang K, Wu S, Li Y. (-)-Lariciresinol isolated from the roots of isatis Indigotica fortune ex Lindl. Inhibits hepatitis B virus by regulating viral transcription. Molecules. 2022;27(10):3223.","journal-title":"Molecules"},{"issue":"3","key":"2970_CR37","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1128\/JVI.77.3.1885-1893.2003","volume":"77","author":"JT Guo","year":"2003","unstructured":"Guo JT, Pryce M, Wang X, Barrasa MI, Hu J, Seeger C. Conditional replication of Duck hepatitis B virus in hepatoma cells. J Virol. 2003;77(3):1885\u201393.","journal-title":"J Virol"},{"key":"2970_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2018.09.001","volume":"159","author":"S Wu","year":"2018","unstructured":"Wu S, Luo Y, Viswanathan U, Kulp J, Cheng J, Hu Z, et al. Cpams induce assembly of HBV capsids with altered electrophoresis mobility: implications for mechanism of inhibiting pgrna packaging. Antiviral Res. 2018;159:1\u201312.","journal-title":"Antiviral Res"},{"issue":"4","key":"2970_CR39","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.apsb.2025.02.033","volume":"15","author":"SJ Xu","year":"2025","unstructured":"Xu SJ, Wang Y, Shi DZ, Wang S, Qiao LJ, Yang G, et al. Discovery and mechanism verification of first-in-class hydrophobic tagging-based degraders of HBV core protein. Acta Pharm Sin B. 2025;15(4):2170\u201396.","journal-title":"Acta Pharm Sin B"},{"issue":"6714","key":"2970_CR40","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1126\/science.adp1453","volume":"385","author":"Q Wang","year":"2024","unstructured":"Wang Q, Wang T, Cao L, Mu A, Fu S, Wang P, et al. Inherent symmetry and flexibility in hepatitis B virus subviral particles. Science. 2024;385(6714):1217\u201324.","journal-title":"Science"},{"issue":"4","key":"2970_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1179\/joc.2008.20.4.458","volume":"20","author":"GY Wu","year":"2008","unstructured":"Wu GY, Zheng XJ, Yin CC, Jiang D, Zhu L, Liu Y, et al. Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly. J Chemother. 2008;20(4):458\u201367.","journal-title":"J Chemother"},{"key":"2970_CR42","doi-asserted-by":"publisher","first-page":"42374","DOI":"10.1038\/srep42374","volume":"7","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Hu T, Zhou X, Wildum S, Garcia-Alcalde F, Xu Z, et al. Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms. Sci Rep. 2017;7:42374.","journal-title":"Sci Rep"},{"issue":"5608","key":"2970_CR43","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.1077215","volume":"299","author":"K Deres","year":"2003","unstructured":"Deres K, Schr\u00f6der CH, Paessens A, Goldmann S, Hacker HJ, Weber O, et al. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science. 2003;299(5608):893\u20136.","journal-title":"Science"},{"issue":"9","key":"2970_CR44","doi-asserted-by":"publisher","first-page":"e1012485","DOI":"10.1371\/journal.ppat.1012485","volume":"20","author":"S Shen","year":"2024","unstructured":"Shen S, Cai D, Liang H, Zeng G, Liu W, Yan R, et al. NEDD4 family ubiquitin ligase AIP4 interacts with alix to enable HBV naked capsid egress in an alix ubiquitination-independent manner. PLoS Pathog. 2024;20(9):e1012485.","journal-title":"PLoS Pathog"},{"issue":"6","key":"2970_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13181","volume":"22","author":"L Zeyen","year":"2020","unstructured":"Zeyen L, D\u00f6ring T, Stieler JT, Prange R. Hepatitis B subviral envelope particles use the COPII machinery for intracellular transport via selective exploitation of Sec24A and Sec23B. Cell Microbiol. 2020;22(6):e13181.","journal-title":"Cell Microbiol"},{"issue":"3","key":"2970_CR46","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/hep.26125","volume":"57","author":"C Sureau","year":"2013","unstructured":"Sureau C, Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology. 2013;57(3):985\u201394.","journal-title":"Hepatology"},{"key":"2970_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.antiviral.2018.12.019","volume":"162","author":"C Li","year":"2019","unstructured":"Li C, Wang Y, Liu T, Niklasch M, Qiao K, Durand S, et al. An E. coli-produced single-chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion. Antivir Res. 2019;162:118\u201329.","journal-title":"Antivir Res"},{"key":"2970_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105549","volume":"146","author":"D Zhang","year":"2022","unstructured":"Zhang D, Wang Z, Li J, Zhu J. Exploring the possible molecular targeting mechanism of saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology. Comput Biol Med. 2022;146:105549.","journal-title":"Comput Biol Med"},{"issue":"4","key":"2970_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2174\/1871526519666190207092307","volume":"20","author":"R Mohan","year":"2020","unstructured":"Mohan R, Venugopal S. Molecular binding and simulation studies of Staphylococcus aureus superantigens with flavonoid compounds. Infect Disord Drug Targets. 2020;20(4):531\u201342.","journal-title":"Infect Disord Drug Targets"},{"key":"2970_CR50","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","volume":"11","author":"P Fisicaro","year":"2020","unstructured":"Fisicaro P, Barili V, Rossi M, Montali I, Vecchi A, Acerbi G, et al. Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches. Front Immunol. 2020;11:849.","journal-title":"Front Immunol"},{"issue":"11","key":"2970_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100893","volume":"5","author":"R Mateo","year":"2023","unstructured":"Mateo R, Xu S, Shornikov A, Yazdi T, Liu Y, May L, et al. Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV\/HDV. JHEP Rep. 2023;5(11):100893.","journal-title":"JHEP Rep"},{"issue":"8","key":"2970_CR52","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1053\/j.gastro.2020.02.058","volume":"158","author":"M Bazinet","year":"2020","unstructured":"Bazinet M, P\u00e2ntea V, Placinta G, Moscalu I, Cebotarescu V, Cojuhari L, et al. Safety and efficacy of 48 weeks REP 2139 or REP 2165, tenofovir disoproxil, and pegylated interferon alfa-2a in patients with chronic HBV infection na\u00efve to nucleos(t)ide therapy. Gastroenterology. 2020;158(8):2180\u201394.","journal-title":"Gastroenterology"},{"issue":"1","key":"2970_CR53","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-virology-092818-015508","volume":"7","author":"S Seitz","year":"2020","unstructured":"Seitz S, Habjani\u010d J, Sch\u00fctz AK, Bartenschlager R. The hepatitis B virus envelope proteins: molecular gymnastics throughout the viral life cycle. Annu Rev Virol. 2020;7(1):263\u201388.","journal-title":"Annu Rev Virol"},{"issue":"24","key":"2970_CR54","doi-asserted-by":"publisher","first-page":"12850","DOI":"10.1128\/JVI.01499-10","volume":"84","author":"K Ito","year":"2010","unstructured":"Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K, Mizokami M, et al. Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol. 2010;84(24):12850\u201361.","journal-title":"J Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02970-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02970-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02970-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:06:42Z","timestamp":1761847602000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02970-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2970"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02970-w","relation":{},"ISSN":["1743-422X"],"issn-type":[{"type":"electronic","value":"1743-422X"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"342"}}